drugs, meds, immunization Flashcards
mild sedative used for trt of nausea in pregnancy w/c can cause phocomelia
thalidomide
thalidomide is still used for trt of?
leprosy
multiple myeloma
physiologic changes w/c affects drug mechanism
dec GI motility, inc gastric pH inc plasma vol dec serum albumin, inc alpha-1 acid glycogen inc renal BF inc hepatic microenzyme hyperventilation, inc TV & pulmo BV inc aqueous and fatty tissue spaces
properties of drug that easily cross placenta
highly lipid soluble
non-ionized
LMW
minimally protein bound
fetal pharmacokinetics affecting drugs
protein binding capacity of fetal plasma is lower than maternal
fetal plasma & amniotic fluid are slightly more acidic
metabolizing capacity of fetal liver enzyme is much less
fetal glomerular filtration is markedly reduce
timing and effect of drugs during pregnancy
20 days
all or nothing; fetus is highly resistant to birth defects
timing and effect of drugs during pregnancy
3-8 wks
possibly no effect miscarriage obvious birth defect inc risk of childhood cancer organogenesis
timing and effect of drugs during pregnancy
2nd & 3rd trim
changes in growth & fx of normally formed organs & tissue
unlikely to cause obvious birth defect
unknown long-term effect
FDA drug categories
A - adequate, well-controlled studies no risk of fetal abnormality
B - no risk in animal, no adequate studies in human; risk in animal, no risk in human
C - risk in animal, no adequate studies in human; no adequate studies in animal & human
D - benefit > risk
X - absolute contraindication
Category C
Corticosteroids, Fluconazole, Methylene Blue, Minoxidil
Category D
ACE inhibitors, Aminocaproic acid, ARBs, Aminoglycosides, Atenolol, Carbamazepine, Methimazole, Mifepristone, RU-486, Penicillamine, Potassium iodine, Diatrizoate, Tetracycline, Valproic acid, Antineoplastics (Alkylating agents), Aspirin, Benzodiazepines, Bromides, Colchicine, Phenytoin, Lithium, Mysoline, Phenobarbital or methylphenobarbital, Megesterol, Norethindrone, Tamoxifen
Category X
Antineoplastics (antimetabolites): Methotrexate, Cytaribine, Chlorambucil, Cycolphosphamide Flurazepam, Triazolam, DES, Finasteride, Misoprostol, Raloxifene, Statins, Acetohydroxamin acid, Androrgens (ex. Danazol), Benzodiazepines, Temazepam, Ergotamine, Progestins, Retinoic acid, Isotretinoin (Accutane), Acitretin (Soriatane), Etretinate, Topical tazarotene, Thalidomide, Warfarin
benzodiazepine (DX)
bradypnea or withdrawal symptoms if given late in pregnancy
aminoglycoside (D)
ototoxicity
nephrotoxicity
chloramphenicol (X)
gray baby syndrome
fluoroquinolone
bone & joint abnormalities esp. in 1st trim
nitrofurantoin (B)
hemolytic anemia at term
2-fold risk of cleft lip at 1st trim
contraindicated in G6PD def
TMP-SMX (D)
TMP: interfere w/ folic acid metab
SMX: jaundice & hemolytic anemia
warfarin (X)
schizencephaly, microcephaly, hydrocephalus, blindness, mental disability, fteal hemorrhage
fluconazole (C)
in animals, fetotoxicity, teratogenicity
spironolactone
anti-androgenic
ACE inhibitors (D)
last trim, fetal kidney damage, oligohydramnios, facial, limb & lung defect, fetal hypotension
what anti-hypertensive drugs can be given safely?
nifedipine
methyldopa
beta-blocker (D)
dec HR & fetal growth restriction
calcium channel blocker
1st trim, birth defect of fingers & toes